| Polymorphism of diflunisal: Isolation and solid‐state characteristics of a new crystal form MC Martinez‐Oharriz, C Martin, MM Goni, C Rodriguez‐Espinosa, ... Journal of pharmaceutical sciences 83 (2), 174-177, 1994 | 75 | 1994 |
| Human serum albumin nanoparticles for ocular delivery of bevacizumab IL de Redín, C Boiero, MC Martínez-Ohárriz, M Agüeros, R Ramos, ... International Journal of Pharmaceutics 541 (1-2), 214-223, 2018 | 71 | 2018 |
| Solid dispersions of diflunisal–PVP: polymorphic and amorphous states of the drug MC Martínez-Ohárriz, C Rodríguez-Espinosa, C Martin, MM Goni, ... Drug development and industrial pharmacy 28 (6), 717-725, 2002 | 66 | 2002 |
| Fluconazole encapsulation in PLGA microspheres by spray-drying PA Rivera, MC Martinez-Oharriz, M Rubio, JM Irache, S Espuelas Journal of microencapsulation 21 (2), 203-211, 2004 | 64 | 2004 |
| Optimization and evaluation of zein nanoparticles to improve the oral delivery of glibenclamide. In vivo study using C. elegans D Lucio, MC Martínez-Ohárriz, G Jaras, P Aranaz, CJ González-Navarro, ... European journal of pharmaceutics and biopharmaceutics 121, 104-112, 2017 | 51 | 2017 |
| Sorption of pindolol and related compounds by a β-cyclodextrin polymer: Isosteric heat of sorption C Gazpio, M Sánchez, JR Isasi, I Vélaz, C Martín, C Martínez-Ohárriz, ... Carbohydrate polymers 71 (1), 140-146, 2008 | 48 | 2008 |
| HPLC and solubility study of the interaction between pindolol and cyclodextrins C Gazpio, M Sánchez, IX García-Zubiri, I Vélaz, C Martínez-Ohárriz, ... Journal of pharmaceutical and biomedical analysis 37 (3), 487-492, 2005 | 44 | 2005 |
| Influence of polyethylene glycol 4000 on the polymorphic forms of diflunisal MC Martınez-Oharriz, C Martın, MM Goñi, C Rodrıguez-Espinosa, ... European journal of pharmaceutical sciences 8 (2), 127-132, 1999 | 44 | 1999 |
| Solubilization and interaction of sulindac with polyvinylpyrrolidone K30 in the solid state and in aqueous solution MC Tros de Llarduya, C Martín, MM Goni, MC Martinez-Oharriz Drug development and industrial pharmacy 24 (3), 295-300, 1998 | 44 | 1998 |
| Interactions of naproxen with vinylpyrrolidone and β-cyclodextrin: a fluorimetric study I Velaz, M Sánchez, C Martın, MC Martınez-Ohárriz, A Zornoza International journal of pharmaceutics 153 (2), 211-217, 1997 | 40 | 1997 |
| In vitro release from reverse poloxamine/α-cyclodextrin matrices: Modelling and comparison of dissolution profiles E Larrañeta, C Martínez-Ohárriz, I Vélaz, A Zornoza, R Machín, JR Isasi Journal of Pharmaceutical Sciences 103 (1), 197-206, 2014 | 38 | 2014 |
| Polymorphism of sulindac: Isolation and characterization of a new polymorph and three new solvates MCT De Ilarduya, C Martin, MM Goni, MC Martinez-Oharriz Journal of pharmaceutical sciences 86 (2), 248-251, 1997 | 36 | 1997 |
| The role of cyclodextrins in ORAC-fluorescence assays. Antioxidant capacity of tyrosol and caffeic acid with hydroxypropyl-β-cyclodextrin M García-Padial, MC Martínez-Ohárriz, I Navarro-Blasco, A Zornoza Journal of agricultural and food chemistry 61 (50), 12260-12264, 2013 | 33 | 2013 |
| Inclusion complexes of nabumetone with β‐cyclodextrins: thermodynamics and molecular modelling studies. Influence of sodium perchlorate N Goyenechea, M Sánchez, I Vélaz, C Martín, MC Martínez‐Ohárriz, ... Luminescence: The journal of biological and chemical luminescence 16 (2 …, 2001 | 31 | 2001 |
| Characterization of complexes between naftifine and cyclodextrins in solution and in the solid state M Uzqueda, C Martín, A Zornoza, M Sánchez, MC Martínez-Ohárriz, ... Pharmaceutical research 23, 980-988, 2006 | 29 | 2006 |
| A fluorimetric study of pindolol and its complexes with cyclodextrins C Gazpio, M Sánchez, A Zornoza, C Martı́n, C Martı́nez-Ohárriz, I Vélaz Talanta 60 (2-3), 477-482, 2003 | 29 | 2003 |
| Solubilization and interaction of sulindac with β-cyclodextrin in the solid state and in aqueous solution MCT Ilarduya, C Martían, MM Goni, MC Martinez-Oharriz Drug development and industrial pharmacy 24 (3), 301-306, 1998 | 29 | 1998 |
| Cyclodextrin-grafted poly (anhydride) nanoparticles for oral glibenclamide administration. In vivo evaluation using C. elegans D Lucio, MC Martínez-Ohárriz, Z Gu, Y He, P Aranaz, JL Vizmanos, ... International Journal of Pharmaceutics 547 (1-2), 97-105, 2018 | 28 | 2018 |
| Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets ME Zugasti, A Zornoza, M del Mar Goni, JR Isasi, I Velaz, C Martin, ... Drug development and industrial pharmacy 35 (10), 1264-1270, 2009 | 28 | 2009 |
| Effect of PEG 4000 on the dissolution rate of naproxen I Vélaz, M Sánchez, C Martin, MC Martínez-Ohárriz European journal of drug metabolism and pharmacokinetics 23, 103-108, 1998 | 26 | 1998 |
